相关实验视频

Updated: Jun 29, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

对固酶抑制剂的新选方法的构建和应用

Chunhua Gao¹, Zhe Wang¹, Xiaojing Liu¹

¹Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao 266073, China.

|May 24, 2024

概括

使用GloSensor技术的新型,具有成本效益的方法,可以有效地选酸化酶 (PDE) 抑制剂. 这种方法通过在具有动态检测能力的活细胞中识别新型PDE抑制剂来帮助药物发现.

科学领域:

生物化学生物化学
酶学是一种酶学.
药物发现药物发现药物发现

背景情况:

固酶 (PDEs) 是关键的酶,可以化循环腺单酸盐 (cAMP) 和循环单酸盐 (cGMP).
对于各种疾病来说,PDEs是一个重要的治疗目标.
现有的PDE抑制剂查方法往往复杂且昂贵,阻碍了药物开发.

研究的目的:

建立和应用一种新的,具有成本效益的选方法,用于固酶 (PDE) 抑制剂.
为了确定具有PDE抑制活性的新型化合物.
开发一种适用于PDE抑制剂高通量查 (HTS) 的方法.

主要方法:

开发一种基于GloSensor技术的新选试验.
测试用于在活细胞中识别PDE抑制剂的应用.
动态检测基质度变化.

主要成果:

成功建立和应用基于GloSensor的选方法.
发现了几种新型化合物,在不同的结构类中表现出PDE抑制活性.
证明该方法用于初步PDE类型确定的能力.

结论:

这种基于GloSensor的新方法为选PDE抑制剂提供了一种低成本,动态和高效的方法.
与传统技术相比,这种方法在高通量选方面具有优势.
发现的化合物代表了针对PDEs的治疗开发的潜在线索.

关键词:

化合物化合物化合物化合物循环的腺单酸盐.循环诺辛单酸盐的使用抑制剂抑制剂抑制剂基化酶是一种基化酶.选方法选方法

更多相关视频

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Published on: November 23, 2019

相关概念视频

Enzyme Inhibition

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...